HSBC Holdings’s Sana Biotechnology SANA Stock Holding History

HSBC Holdings’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Buy	111,959 +39,765	+55%	+$128K	﹤0.01%	2392
2026 Q1	$205K	Sell	72,194 -21,870	-23%	-$86.1K	﹤0.01%	2602
2025 Q4	$375K	Buy	94,064 +15,836	+20%	+$70.9K	﹤0.01%	2431
2025 Q3	$269K	Buy	78,228 +52,487	+204%	+$190K	﹤0.01%	2372
2025 Q2	$74.8K	Sell	25,741 -15,636	-38%	-$32.3K	﹤0.01%	2890
2025 Q1	$64.7K	Buy	41,377 +8,673	+27%	+$24.2K	﹤0.01%	2875
2024 Q4	$52.5K	Buy	32,704 +19,084	+140%	+$56.9K	﹤0.01%	2981
2024 Q3	$57.3K	Buy	+13,620	New	+$71.6K	﹤0.01%	2869
2024 Q2	–	Sell	-11,840	Closed	-$118K	–	3143
2024 Q1	$118K	Buy	+11,840	New	+$88.7K	﹤0.01%	2813
2023 Q4	–	Sell	-19,540	Closed	-$75.3K	–	2892
2023 Q3	$75.3K	Buy	+19,540	New	+$105K	﹤0.01%	2587
2022 Q3	–	Sell	-11,047	Closed	-$71K	–	3221
2022 Q2	$71K	Hold	11,047	–	–	﹤0.01%	3095
2022 Q1	$90K	Buy	+11,047	New	+$89.3K	﹤0.01%	3139

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

HSBC Holdings's SANA Position: Q2 2026 in Review

HSBC Holdings increased its Sana Biotechnology (SANA) stake by 55% in Q2 2026, buying an estimated $128K and bringing the position to 111,959 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

HSBC Holdings first reported a position in SANA in Q1 2022 and has held it in 12 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

HSBC Holdings held 111,959 shares of Sana Biotechnology worth $392K as of Q2 2026.
HSBC Holdings bought 39,765 Sana Biotechnology shares in Q2 2026, an estimated $128K.
Sana Biotechnology made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2392 holding.
HSBC Holdings first reported a position in Sana Biotechnology in Q1 2022 and has held it in 12 quarters since.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.